Tobacco habits modulate autosomal dominant nocturnal frontal lobe epilepsy

被引:41
作者
Brodtkorb, Eylert [1 ]
Picard, Fabienne
机构
[1] Univ Trondheim, St Olavs Hosp, Dept Neurol & Clin Neurophysiol, N-7006 Trondheim, Norway
[2] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway
[3] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland
[4] Med Sch Geneva, Geneva, Switzerland
关键词
epilepsy; nicotine; genetics; nocturnal frontal lobe epilepsy;
D O I
10.1016/j.yebeh.2006.07.008
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Mutations in neuronal nicotinic acetylcholine receptors have been demonstrated in autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). The beneficial effect of nicotine administration was previously reported in one single case. We investigated the influence of the tobacco habits of 22 subjects from two pedigrees with alpha 4 mutations (776ins3 and S248F). Subjects were interviewed with respect to pattern of nicotine intake and seizures. Seizure freedom was significantly associated with tobacco use (P = 0.024). All seven nonsmokers with manifest ADNFLE had persistent seizures. Seizure fluctuations, including long remissions, corresponded to changes in tobacco habits in several patients. One patient who recently had begun treatment with transdermal nicotine experienced improvement. We conclude that tobacco appears to be an environmental factor that influences seizure susceptibility in ADNFLE. Inactivation by desensitization of the mutant receptors by nicotine may explain the beneficial effect. The efficacy and safety of transdermal nicotine in ADNFLE should be further explored. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:515 / 520
页数:6
相关论文
共 22 条
[1]   Smokeless tobacco as a possible risk factor for stroke in men - A nested case-control study [J].
Asplund, K ;
Nasic, S ;
Janlert, U ;
Stegmayr, B .
STROKE, 2003, 34 (07) :1754-1759
[2]   How mutations in the nAChRs can cause ADNFLE epilepsy [J].
Bertrand, D ;
Picard, F ;
Le Hellard, S ;
Weiland, S ;
Favre, I ;
Phillips, H ;
Bertrand, S ;
Berkovic, SF ;
Malafosse, A ;
Mulley, J .
EPILEPSIA, 2002, 43 :112-122
[3]   Molecular and cellular aspects of nicotine abuse [J].
Dani, JA ;
Heinemann, S .
NEURON, 1996, 16 (05) :905-908
[4]   Nicotine replacement therapy and cardiovascular disease [J].
Ford, CL ;
Zlabek, JA .
MAYO CLINIC PROCEEDINGS, 2005, 80 (05) :652-656
[5]   A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chromosome 1 [J].
Gambardella, A ;
Annesi, G ;
De Fusco, M ;
Patrignani, A ;
Aguglia, U ;
Annesi, F ;
Pasqua, AA ;
Spadafora, P ;
Oliveri, RL ;
Valentino, P ;
Zappia, M ;
Ballabio, A ;
Casari, G ;
Quattrone, A .
NEUROLOGY, 2000, 55 (10) :1467-1471
[6]   What genes tell us about nicotine addiction [J].
Hogg, RC ;
Bertrand, D .
SCIENCE, 2004, 306 (5698) :983-+
[7]   Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors [J].
Kuryatov, A ;
Luo, J ;
Cooper, J ;
Lindstrom, J .
MOLECULAR PHARMACOLOGY, 2005, 68 (06) :1839-1851
[8]   Schizophrenia, psychotic illness and other psychiatric symptoms in families with autosomal dominant nocturnal frontal lobe epilepsy caused by different mutations [J].
Magnusson, A ;
Stordal, E ;
Brodtkorb, E ;
Steinlein, O .
PSYCHIATRIC GENETICS, 2003, 13 (02) :91-95
[9]   Autosomal dominant frontal epilepsy [J].
Magnusson, A ;
Nakken, KO ;
Brubakk, E .
LANCET, 1996, 347 (9009) :1191-1192
[10]   Phenotypic comparison of two Scottish families with mutations in different genes causing autosomal dominant nocturnal frontal lobe epilepsy [J].
McLellan, A ;
Phillips, HA ;
Rittey, C ;
Kirkpatrick, M ;
Mulley, JC ;
Goudie, D ;
Stephenson, JBP ;
Tolmie, J ;
Scheffer, IE ;
Berkovic, SF ;
Zuberi, SM .
EPILEPSIA, 2003, 44 (04) :613-617